SAGES colorectal and metabolic bariatric surgery committee joint task force call to action for synchronized severe obesity and colorectal cancer management - Report - MDSpire

SAGES colorectal and metabolic bariatric surgery committee joint task force call to action for synchronized severe obesity and colorectal cancer management

  • By

  • Andreas M. Kaiser

  • Heather Carmichael

  • Lawrence Lee

  • Nathan Aminpour

  • Nawar A. Alkhamesi

  • Ana Sofia Ore

  • Siva Dantu

  • Evelyn Janet Bonilla

  • Teresa deBeche-Adams

  • Mukta K. Krane

  • Farah A. Husain

  • Omar M. Ghanem

  • Nour El Ghazal

  • Patricia Sylla

  • Elisabeth C. McLemore

  • May 18, 2026

  • 0 min

Share

Joint Initiative by SAGES on Severe Obesity and Colorectal Cancer Management

Overview

The SAGES Colorectal and Metabolic Bariatric Surgery Committee highlights the critical intersection of severe obesity and colorectal cancer management. The report emphasizes the need for integrated approaches to address obesity concurrently with cancer treatment to improve patient outcomes.

Background

The rising prevalence of obesity, particularly severe obesity, poses significant challenges in managing colorectal cancer (CRC). Obesity is associated with increased cancer risk and complicates surgical interventions, necessitating a reevaluation of treatment strategies. Understanding the implications of obesity on CRC management is essential for optimizing patient care and outcomes.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

  • Severe obesity complicates CRC management due to increased operative risks and technical challenges.
  • Obesity is linked to a higher incidence of CRC, with up to 38% of cases attributable to excess adiposity.
  • Weight loss interventions can improve inflammatory and metabolic biomarkers associated with cancer risk.
  • Concurrent management of obesity during CRC treatment may enhance therapeutic outcomes.
  • There is a critical need for multidisciplinary approaches to integrate weight-loss strategies into oncologic care pathways.

Clinical Implications

Healthcare providers should consider integrating obesity management into CRC treatment plans to mitigate risks and improve surgical outcomes. Coordinated care involving multidisciplinary teams can enhance the effectiveness of both obesity and cancer treatments.

Conclusion

Addressing severe obesity in the context of colorectal cancer management is vital for improving patient outcomes. Future research should focus on developing integrated treatment pathways that prioritize both obesity and cancer care.

Related Resources & Content

  1. SAGES Colorectal and Metabolic Bariatric Surgery Committee, Surgical Endoscopy, 2024 -- Joint Initiative on Severe Obesity and CRC Management
  2. Techniques in Coloproctology — Interdisciplinary Strategies for Minimally Invasive Colorectal Cancer Surgery in Obese Patients
  3. Surgical Endoscopy — Amendment: Updated SAGES Recommendations for Managing Comorbidities Associated with Metabolic and Bariatric Surgery
  4. The New Gastroenterologist — The Advancements in Obesity Treatment Approaches
  5. Interdisciplinary Strategies for Minimally Invasive Colorectal Cancer Surgery in Obese Patients
  6. Updated SAGES Recommendations for Managing Comorbidities Associated with Metabolic and Bariatric Surgery
  7. Guidelines for Addressing Comorbid Conditions in Metabolic and Bariatric Surgical Practices
  8. The Advancements in Obesity Treatment Approaches
  9. Overweight and obesity significantly increase colorectal cancer risk: a meta-analysis of 66 studies revealing a 25–57% elevation in risk
  10. Robotic-assisted versus laparoscopic surgery for colorectal cancer in high-risk patients: a systematic review and meta-analysis
  11. Outcomes of Metabolic and Bariatric Surgery in Populations with Obesity and Their Risk of Developing Colorectal Cancer

Original Source(s)

SAGES colorectal and metabolic bariatric surgery committee joint task force call to action for synchronized severe obesity and colorectal cancer management

  • by Andreas M. Kaiser, Heather Carmichael, Lawrence Lee, Nathan Aminpour, Nawar A. Alkhamesi, Ana Sofia Ore, Siva Dantu, Evelyn Janet Bonilla, Teresa deBeche-Adams, Mukta K. Krane, Farah A. Husain, Omar M. Ghanem, Nour El Ghazal, Patricia Sylla, Elisabeth C. McLemore

  • May 18, 2026

Related Content

Tracing the stemness and malignant transition in a heritable colorectal cancer Lynch Syndrome by single-cell RNA-seq analysis

Clinical-scale 10-day TCR-T cell manufacturing using IL-2/7/15 and TGF-β promotes early memory and tissue-resident-like phenotypes and robust antitumor activity in vitro

A Meta-Analysis on the Effectiveness and Safety of FOLFOX Plus Bevacizumab for Colorectal Cancer Treatment